FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
Links shared publicly online about this topic.
- 180total visits
FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
View full resource at drugs.com
Tags: Pain, Cancer, Cancer Pain Medication, Nose, FDA, Duragesic, Actiq
Most Recently Shared on July 1, 2011 at 1:08 am By:
FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Pati... http://bit.ly/mxmtJE #drug
Medical News: FDA Okays Nasal Spray for Ca Pain - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at medpagetoday.com
Most Recently Shared on July 5, 2011 at 4:51 pm By:
New nasal spray to treat pain in cancer patients is approved by the #FDA http://bit.ly/k9MyZr
FDA Okays Nasal Spray for Ca Pain - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at qualitypointtech.net
Most Recently Shared on July 2, 2011 at 1:45 pm By:
FDA Okays Nasal Spray for Ca Pain: WASHINGTON (MedPage Today) -- The FDA has approved a nasal spray formulation of... http://bit.ly/mpdinQ
Medical News: FDA Okays Nasal Spray for Ca Pain - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at medpagetoday.com
Most Recently Shared on July 2, 2011 at 1:27 pm By:
FDA Okays Nasal Spray for Ca Pain http://bit.ly/l97juH
Medical News: FDA Okays Nasal Spray for Ca Pain - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at medpagetoday.com
Most Recently Shared on July 2, 2011 at 1:16 pm By:
FDA Okays Nasal Spray for Ca Pain http://bit.ly/j6KrSw
Lazanda Approved for Breakthrough Cancer Pain - ONA
oncologynurseadvisor.com — “Archimedes Pharma U.S. Inc. announced that the FDA has approved Lazanda (fentanyl) nasal spray for the management of breakthrough pain in cancer patients ?18 years who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 1, 2011 at 1:57 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Lazanda Approved for Breakthrough Cancer Pain http://goo.gl/fb/koVKh
FDA Approves Lazanda (Fentanyl) Nasal Spray for Breakthrough Cancer Pain
disabled-world.com — “FDA approved Lazanda (fentanyl) nasal spray for management of breakthrough pain in cancer patients 18 years and older already receiving and are tolerant to opioid therapy for underlying persistent cancer pain” View full resource at disabled-world.com
Most Recently Shared on June 30, 2011 at 11:03 pm By:
Disabled World Health Advocate and Health News
FDA Approves Lazanda (Fentanyl) Nasal Spray for Breakthrough Cancer Pain http://ff.im/-H07aY
Advertisement
